HCAT — HEALTH CATALYST INC

Ownership history in Stonepine Capital Management, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Stonepine Capital Management, LLC reported a position in HEALTH CATALYST INC (HCAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.37% (2025 Q2)
Avg. % of fund
0.37%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 155,551 +55,551 +55.6% 0.36% $443.3M $2.85
2025 Q2 INITIATED 100,000 — — 0.37% $377K $3.77
% of Fund (quarterly)    HCAT price (monthly, adj. close)

Other funds also holding HCAT

As of 2025 Q4 — sorted by position size

Whetstone Capital Advisors, LLC 3Y 7Y 2.8% First Light Asset Management, LLC 3Y 7Y 2.36% Nepsis Inc. 3Y 7Y 1.41% Palogic Value Management, L.P. 3Y 1.27% HighMark Wealth Management LLC 3Y 0.72% MARTIN & CO INC /TN/ 3Y 7Y 0.21% PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.07% CVS HEALTH Corp 3Y 0.06% nVerses Capital, LLC 0.06% Williams & Novak, LLC 0.05%
← Back to Stonepine Capital Management, LLC Holdings